Renub Research has announced the addition of the China Molecular Diagnostics Market, Test Volume & Forecast report to its offering
Online PR News – 04-January-2017 – Roswell, Georgia – Molecular Diagnostics market in China is very lucrative industry and it’s growing in leaps and bounds. China Molecular Diagnostics Market is dominated to two tests. Virology Testing and Colorectal Cancer together controls more than 80 percent of market share in China. Virology testing has the highest market share. Virology is the study of viruses and virus–like agents: their structure, classification and evolution. Virology Tests are used to detect infectious ailments such as Influenza, Polio, Hepatitis, Yellow Fever, AIDs, Diarrhea, Measles, Common cold etc.
Whereas, Colorectal cancer test has the second highest market share. In China, Colorectal cancer (CRC) has attracted increasing attention over recent years, taking a second and fourth position in the incidence and mortality lists respectively among all malignant tumors in urban populations.
Third spot is being taken by Breast Cancer and Breast Screening has taken the 4th place. Breast cancer is a leading cause of death among women in China, with 1.1 Million new cases annually. China’s breast cancer mortality has doubled over the past 30 years.
Research report “China Molecular Diagnostics Market, Test Volume & Forecast” provides market data and forecast from 2010 to 2015 (past and present data) and 2016 to 2020 (forecast data) of all the segments of China Molecular Diagnostics.
• Oncology Testing Market & Forecast
• Breast Cancer Testing Market & Forecast
• Colorectal Cancer Testing Market & Forecast
• Prostate Cancer Testing Market & Forecast
• Infectious Disease Testing Market & Forecast
• Virology Testing Market & Forecast
• HPV Testing Market & Forecast
• Genetic Testing Market & Forecast
• Blood Screening Market & Forecast
• HLA Testing Market & Forecast
Related News: http://www.renub.com/china-molecular-diagnostics-market-share-of-breast-cancer-virology-colorectal-cancer-prostate-cancer-hpv-blood-screening-and-hla-tests-12-nd.php